Pemigatinib

Pemigatinib, sold under the brand name Pemazyre, is an anti-cancer medication used for the treatment of bile duct cancer (cholangiocarcinoma).[1][2][3][4] Pemigatinib works by blocking FGFR2 in tumor cells to prevent them from growing and spreading.[3] Pemigatinib belongs to a group of medicines called protein kinase inhibitors.[5] It works by blocking enzymes known as protein kinases, particularly... [wikipedia]